Foresight Diagnostics Patent Issued for Minimal Residual Disease Detection Technology
The USPTO granted Foresight Diagnostics a patent for the detection of MRD using its personalized phased variant detection platform.
Read More
Search Results for: lung cancer
Biosensor Detects Brain Tumors with Less Than a Drop of Blood
Researchers have developed a biosensor that could help physicians precisely diagnose brain cancer from a minute blood sample.
Read More
Novel Blood Test Evaluates Severity in Pulmonary Arterial Hypertension
Researchers found that a novel blood test can be used to easily evaluate disease severity in patients with pulmonary arterial hypertension.
Read More
Blood Test that Can Identify Laminin 332 Launched
KSL Beutner Laboratories (Beutner) has launched an IIF serum blood test in the U.S. that positively identifies laminin 332.
Read More
Artemis DNA Cuts Texas Operations, Shifts Focus to Oncology Portfolio in California
Global diagnostic laboratory company Artemis DNA closed its Houston, Texas facility to optimize the company’s strategy in California.
Read More